Tech Company Financing Transactions
MediciNova Funding Round
MediciNova, based in La Jolla, secured $44 million in funding from EW Healthcare Partners and Posco BioVentures.
Transaction Overview
Company Name
Announced On
9/3/2004
Transaction Type
Venture Equity
Amount
$44,000,000
Round
Series C
Investors
EW Healthcare Partners (Lead Investor)
Proceeds Purpose
Capital that allows us to advance the development of several clinical projects and to continue to add new products to our portfolio.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4275 Executive Sq. 650
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
MediciNova, Inc. is a privately held specialty pharmaceutical company focused on accelerating the global development and commercialization of innovative pharmaceutical products. MediciNova's pipeline targets a variety of prevalent medical conditions, including preterm labor, cancer, asthma and anxiety disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yuichi Iwaki
Chief Financial Officer
Carla Reyes
Chief Medical Officer
Kazuko Matsuda
Vice President
Geoffrey O'Brien
Vice President
Masatsune Okajima
Browse more venture capital transactions:
Prev: 9/3/2004: Vascular Architects venture capital transaction
Next: 9/6/2004: Sopherion Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs